SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies-Reference-Cited by-同舟云学术

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies

Published:2022-08 Issue:8 Volume:30 Page:1103-1111.e6
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Arora Prerna,Zhang Lu,Krüger Nadine,Rocha Cheila,Sidarovich Anzhalika,Schulz Sebastian,Kempf Amy,Graichen Luise,Moldenhauer Anna-Sophie,Cossmann Anne,Dopfer-Jablonka Alexandra,Behrens Georg M.N.,Jäck Hans-Martin,Pöhlmann Stefan^ORCID,Hoffmann Markus

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference52 articles.

1. Effect of mRNA vaccine boosters against SARS-CoV-2 omicron infection in Qatar;Abu-Raddad;N. Engl. J. Med.,2022

2. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 omicron and Delta variants;Accorsi;JAMA,2022

3. Protection against the omicron variant from previous SARS-CoV-2 infection;Altarawneh;N. Engl. J. Med.,2022

4. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination;Arora;Cell Rep.,2021

5. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3;Arora;Lancet Infect. Dis.,2022

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring early COVID-19 therapies, variants, and viral clearance dynamics: Insights from a high-risk outpatients study;Diagnostic Microbiology and Infectious Disease;2024-10

2. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

3. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency;Cell;2024-02

4. Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2;Journal of Infection and Public Health;2024-02

5. Escalating combinations of enhanced infectivity and immune escape define SARS-CoV-2 Omicron lineage replacement;2024-01-04